Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Shehadeh

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
The Lancet. Diabetes & Endocrinology|April 4, 2022
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 studyWilliam V Tamborlane, Lori M Laffel, Naim Shehadeh, et al.
Frontiers in Endocrinology|January 27, 2023
Screening for non-classic congenital adrenal hyperplasia in women: New insights using different immunoassaysAfif Nakhleh, Leonard Saiegh, Naim Shehadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosisNaim Shehadeh, Shirly Pollack, Gizi Wildbaum, et al.
Biomedicines|February 26, 2025
Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing ExplainabilityRajashekar Korutla, Douglas Tedder, Kathryn Brogan, et al.
Diabetes Care|September 19, 2019
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical TrialLawrence Blonde, Julio Rosenstock, Stefano Del Prato, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 9, 2009
Oral insulin supplementation in paediatric short bowel disease: a pilot observational studyRaanan Shamir, Sanja Kolacek, Sibylle Koletzko, et al.
Diabetes, Obesity & Metabolism|April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuriaAfif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Pediatric Diabetes|October 20, 2019
Identifying sources of support and barriers to physical activity in pediatric type 1 diabetesRuth Livny, Wasim Said, Smadar Shilo, et al.
Pediatric Diabetes|December 14, 2011
Increase in the incidence of type 1 diabetes in Israeli children following the Second Lebanon WarAmnon Zung, Orit Blumenfeld, Naim Shehadeh, et al.
Diabetes|October 28, 2003
Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathwayPål R Njølstad, Jørn V Sagen, Lise Bjørkhaug, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
The Lancet. Diabetes & Endocrinology|April 4, 2022
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 studyWilliam V Tamborlane, Lori M Laffel, Naim Shehadeh, et al.
Frontiers in Endocrinology|January 27, 2023
Screening for non-classic congenital adrenal hyperplasia in women: New insights using different immunoassaysAfif Nakhleh, Leonard Saiegh, Naim Shehadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosisNaim Shehadeh, Shirly Pollack, Gizi Wildbaum, et al.
Biomedicines|February 26, 2025
Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing ExplainabilityRajashekar Korutla, Douglas Tedder, Kathryn Brogan, et al.
Diabetes Care|September 19, 2019
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical TrialLawrence Blonde, Julio Rosenstock, Stefano Del Prato, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 9, 2009
Oral insulin supplementation in paediatric short bowel disease: a pilot observational studyRaanan Shamir, Sanja Kolacek, Sibylle Koletzko, et al.
Diabetes, Obesity & Metabolism|April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuriaAfif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Pediatric Diabetes|October 20, 2019
Identifying sources of support and barriers to physical activity in pediatric type 1 diabetesRuth Livny, Wasim Said, Smadar Shilo, et al.
Pediatric Diabetes|December 14, 2011
Increase in the incidence of type 1 diabetes in Israeli children following the Second Lebanon WarAmnon Zung, Orit Blumenfeld, Naim Shehadeh, et al.
Diabetes|October 28, 2003
Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathwayPål R Njølstad, Jørn V Sagen, Lise Bjørkhaug, et al.
Pageof 11